Next Article in Journal
Cytotoxic 1,3-Thiazole and 1,2,4-Thiadiazole Alkaloids from Penicillium oxalicum: Structural Elucidation and Total Synthesis
Previous Article in Journal
Sesquiterpenoids from Chinese Agarwood Induced by Artificial Holing
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessArticle
Molecules 2016, 21(3), 271;

Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities

Department of Therapeutical Chemistry, Pharmaceutical and Drug Industries Division, National Research Centre, Giza 12622, Egypt
Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
Department of Pharmaceutical Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt
Author to whom correspondence should be addressed.
Academic Editor: Maria Emília de Sousa
Received: 3 December 2015 / Revised: 16 February 2016 / Accepted: 19 February 2016 / Published: 26 February 2016
(This article belongs to the Section Bioorganic Chemistry)
Full-Text   |   PDF [552 KB, uploaded 2 March 2016]   |  


With the aim of developing novel antitumor scaffolds, a novel series of polysubstituted pyrazole derivatives linked to different nitrogenous heterocyclic ring systems at the C-4 position were synthesized through different chemical reactions and characterized by means of spectral and elemental analyses and their antiproliferative activity against 60 different human tumor cell lines was validated by the U.S. National Cancer Institute using a two stage process. The in vitro anticancer evaluation revealed that compound 9 showed increased potency toward most human tumor cell lines with GI50MG-MID = 3.59 µM, as compared to the standard drug sorafenib (GI50 MG-MID = 1.90 µM). At the same time, compounds 6a and 7 were selective against the HOP-92 cell line of non-small cell lung cancer with GI50 1.65 and 1.61 µM, respectively. View Full-Text
Keywords: 1,3,4-polysubstituted pyrazole derivatives; anticancer agents; synthesis 1,3,4-polysubstituted pyrazole derivatives; anticancer agents; synthesis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Fahmy, H.H.; Khalifa, N.M.; Ismail, M.M.F.; El-Sahrawy, H.M.; Nossier, E.S. Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities. Molecules 2016, 21, 271.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top